Macquarie Group LTD Repligen Corp Transaction History

Macquarie Group LTD

$87.4 Billion
Q1 2024

A detailed history of Macquarie Group LTD transactions in Repligen Corp stock. As of the latest transaction made, Macquarie Group LTD holds 1,464,602 shares of RGEN stock, worth $218 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

1,464,602

Previous 1,568,792 6.64%

Holding current value

$218 Million

Previous $282 Million 4.5%

% of portfolio

0.31%

Previous 0.33%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$170.78 - $208.42 $17.8 Million - $21.7 Million	-104,190 Reduced 6.64%	1,464,602 $269 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $35 Million - $56.9 Million	306,748 Added 24.31%	1,568,792 $282 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $4.27 Million - $5.43 Million	30,752 Added 2.5%	1,262,044 $201 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $13.7 Million - $17.8 Million	98,673 Added 8.71%	1,231,292 $174 Million
Q1 2023 May 15, 2023	BUY	$154.26 - $198.1 $4.75 Million - $6.11 Million	30,818 Added 2.8%	1,132,619 $191 Million

Q4 2022 Feb 21, 2023	BUY	$162.42 - $220.56 $39.6 Million - $53.8 Million	243,921 Added 28.43%	1,101,801 $187 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $3.67 Million - $5.87 Million	22,905 Added 2.74%	857,880 $161 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $45.2 Million - $60.3 Million	-320,958 Reduced 27.77%	834,975 $136 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $29.1 Million - $46.5 Million	180,309 Added 18.48%	1,155,933 $217 Million
Q4 2021 Feb 11, 2022	BUY	$247.59 - $304.47 $123 Million - $151 Million	497,184 Added 103.92%	975,624 $258 Million
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $6.52 Million - $10.9 Million	33,495 Added 7.53%	478,440 $138 Million
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $56.9 Million - $75.8 Million	343,025 Added 336.56%	444,945 $88.8 Million
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $1.38 Million - $1.73 Million	7,661 Added 8.13%	101,920 $19.8 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $4.04 Million - $5.63 Million	-27,252 Reduced 22.43%	94,259 $18.1 Million
Q3 2020 Nov 13, 2020	SELL	$122.51 - $158.27 $53.7 Million - $69.3 Million	-437,961 Reduced 78.28%	121,511 $17.9 Million
Q2 2020 Aug 11, 2020	SELL	$94.33 - $140.48 $34.7 Million - $51.6 Million	-367,599 Reduced 39.65%	559,472 $69.2 Million
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $3.3 Million - $4.24 Million	-38,891 Reduced 4.03%	927,071 $89.5 Million
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $6.73 Million - $8.48 Million	91,083 Added 10.41%	965,962 $89.4 Million
Q3 2019 Nov 14, 2019	SELL	$76.65 - $95.51 $8.44 Million - $10.5 Million	-110,168 Reduced 11.18%	874,879 $67.1 Million
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $7.32 Million - $11.6 Million	-135,077 Reduced 12.06%	985,047 $84.7 Million
Q1 2019 May 15, 2019	BUY	$49.45 - $62.8 $2.72 Million - $3.45 Million	54,944 Added 5.16%	1,120,124 $66.2 Million
Q4 2018 Feb 15, 2019	SELL	$48.26 - $68.88 $6.24 Million - $8.9 Million	-129,250 Reduced 10.82%	1,065,180 $56.2 Million
Q3 2018 Nov 15, 2018	BUY	$46.8 - $58.97 $4.06 Million - $5.11 Million	86,739 Added 7.83%	1,194,430 $66.2 Million
Q2 2018 Aug 14, 2018	BUY	$35.26 - $47.04 $4.27 Million - $5.7 Million	121,157 Added 12.28%	1,107,691 $52.1 Million
Q1 2018 May 11, 2018	BUY	$30.92 - $37.27 $3.13 Million - $3.77 Million	101,265 Added 11.44%	986,534 $35.7 Million
Q4 2017 Feb 15, 2018	BUY	$32.53 - $38.92 $4.32 Million - $5.17 Million	132,836 Added 17.65%	885,269 $32.1 Million
Q3 2017 Nov 08, 2017	BUY	$36.98 - $46.06 $27.8 Million - $34.7 Million	752,433	752,433 $28.8 Million

Others Institutions Holding RGEN

# of Institutions

522

Shares Held

53.2M

Call Options Held

1.05M

Put Options Held

228K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.27B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Repligen Corp Transaction History